BioDelivery Sciences International, Inc. (BDSI) — Financial statements
Income statement, balance sheet, and cash flow for BioDelivery Sciences International, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 167↑6.5% | 156↑40.5% | 111↑100.2% | 56↓10.2% | 62 | |
| Cost of Revenue | 23↓5.2% | 25↑14.2% | 22↑36.8% | 16↓19.0% | 19 | |
| Gross Profit | 143↑8.7% | 132↑46.8% | 90↑125.3% | 40↓6.2% | 42 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00↓100.0% | 5↓62.4% | 13 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00↓100.0% | 59↓0.5% | 59 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 106↑7.5% | 99↑14.8% | 86↑46.9% | 59↓0.5% | 59 | |
| Other Expenses | 0.00↑100.0% | -0.00↓175.0% | 0.00↑128.6% | -0.01↑46.2% | -0.03 | |
| Operating Expenses | 106↑7.5% | 99↑14.8% | 86↑35.5% | 64↓11.7% | 72 | |
| Total Costs & Expenses | 130↑4.9% | 123↑14.7% | 108↑35.8% | 79↓13.3% | 91 | |
| Operating Results | ||||||
| Operating Income | 37↑12.6% | 33↑782.7% | 4↑115.8% | -24↑19.6% | -29 | |
| Depreciation & Amortization | 7↓1.2% | 8↓14.9% | 9↑49.8% | 6↓3.6% | 6 | |
| EBITDA | 45↑10.0% | 40↑222.2% | 13↑170.7% | -18↓543.2% | 4 | |
| EBIT | 37↑12.6% | 33↑781.7% | 4↑115.8% | -24↓1021.4% | -2 | |
| Interest & Other Income | ||||||
| Net Interest Income | -7↓6.9% | -7↑63.2% | -19↓86.8% | -10↓18.8% | -9 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 7↑6.9% | 7↓63.2% | 19↑86.8% | 10↑18.8% | 9 | |
| Non-Operating Income | 0.01↑100.0% | 0.00↑175.0% | -0.00↓128.6% | 0.01↑100.1% | -27 | |
| Other Income / Expenses | -8↓6.9% | -7↑63.1% | -19↓86.5% | -10↓154.5% | 19 | |
| Income Before Tax | 30↑14.1% | 26↑269.7% | -15↑54.8% | -34↓216.8% | -11 | |
| Income Tax Expense | -55↓22019.8% | 0.25↑4940.0% | 0.01↓61.5% | 0.01↑100.1% | -16 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 85↑230.1% | 26↑268.0% | -15↑54.8% | -34↓740.8% | 5 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 85↑230.1% | 26↑268.0% | -15↑54.8% | -34↓740.8% | 5 | |
| Bottom-Line Net Income | 85↑230.1% | 26↑268.0% | -15↑67.0% | -46↓977.3% | 5 | |
| EPS (Basic) | 0.82↑215.4% | 0.26↑244.4% | -0.18↑66.7% | -0.54↓640.0% | 0.10 | |
| EPS (Diluted) | 0.82↑241.7% | 0.24↑233.3% | -0.18↑66.7% | -0.54↓700.0% | 0.09 | |
| Weighted Average Shares | 103↑3.5% | 100↑20.0% | 83↑31.7% | 63↑14.1% | 55 | |
| Weighted Average Diluted Shares | 103↓1.7% | 105↑26.3% | 83↑31.7% | 63↑12.0% | 56 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.